Cargando…
The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial
Modulation of cytokine production using immunonutrition is a relatively novel concept to improve outcomes among patients with SARS-CoV-2 infection and is now hypothesized to help manage COVID-19, however, clinical evidence is lacking. This prospective, double-blinded, randomized parallel-controlled...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160844/ https://www.ncbi.nlm.nih.gov/pubmed/34069549 http://dx.doi.org/10.3390/antiox10050804 |
_version_ | 1783700375214227456 |
---|---|
author | Abulmeaty, Mahmoud M. A. Aljuraiban, Ghadeer S. Shaikh, Sumaya M. ALEid, Naif E. Mazrou, Lulwa R. Al Turjoman, Abdullah A. Aldosari, Mona S. Razak, Suhail El-Sayed, Mervat M. Areabi, Tahani M. Alsalafi, Rokia M. Al-Helio, Yasser S. Almutairy, Abdulrhman B. Molla, Haneen N. |
author_facet | Abulmeaty, Mahmoud M. A. Aljuraiban, Ghadeer S. Shaikh, Sumaya M. ALEid, Naif E. Mazrou, Lulwa R. Al Turjoman, Abdullah A. Aldosari, Mona S. Razak, Suhail El-Sayed, Mervat M. Areabi, Tahani M. Alsalafi, Rokia M. Al-Helio, Yasser S. Almutairy, Abdulrhman B. Molla, Haneen N. |
author_sort | Abulmeaty, Mahmoud M. A. |
collection | PubMed |
description | Modulation of cytokine production using immunonutrition is a relatively novel concept to improve outcomes among patients with SARS-CoV-2 infection and is now hypothesized to help manage COVID-19, however, clinical evidence is lacking. This prospective, double-blinded, randomized parallel-controlled interventional clinical trial investigated the effect of antioxidant supplements on inflammatory cytokines and disease progression in non-critically ill patients. A total of 87 hospitalized COVID-19 patients were randomized using computer-generated-randomization into the supplement group (n = 18) and the placebo group (n = 16) for 10 days. Baseline and final nutritional screening via nutrition risk screening (NRS-2002) and subjective global assessment (SGA), as well as the recording of anthropometric, clinical, biochemical, and functional parameters, were done. Serum ferritin level, cytokine storm parameters such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein 1(MCP-1), C-reactive protein, total leukocyte count, lymphocytic count, and neutrophil-to-lymphocyte ratio were measured. Anthropometric and clinical parameters showed nonsignificant differences between groups. The hematology profile showed improvement in lymphocyte count in the supplement group. However, levels of alkaline phosphatase, IL-6, TNF-α, and MCP-1 were significantly lower in the supplement group. In conclusion, antioxidant oral supplementation significantly reduced the cytokine storm and led to partial improvements in clinical parameters among patients with non-critical COVID-19. |
format | Online Article Text |
id | pubmed-8160844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81608442021-05-29 The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial Abulmeaty, Mahmoud M. A. Aljuraiban, Ghadeer S. Shaikh, Sumaya M. ALEid, Naif E. Mazrou, Lulwa R. Al Turjoman, Abdullah A. Aldosari, Mona S. Razak, Suhail El-Sayed, Mervat M. Areabi, Tahani M. Alsalafi, Rokia M. Al-Helio, Yasser S. Almutairy, Abdulrhman B. Molla, Haneen N. Antioxidants (Basel) Article Modulation of cytokine production using immunonutrition is a relatively novel concept to improve outcomes among patients with SARS-CoV-2 infection and is now hypothesized to help manage COVID-19, however, clinical evidence is lacking. This prospective, double-blinded, randomized parallel-controlled interventional clinical trial investigated the effect of antioxidant supplements on inflammatory cytokines and disease progression in non-critically ill patients. A total of 87 hospitalized COVID-19 patients were randomized using computer-generated-randomization into the supplement group (n = 18) and the placebo group (n = 16) for 10 days. Baseline and final nutritional screening via nutrition risk screening (NRS-2002) and subjective global assessment (SGA), as well as the recording of anthropometric, clinical, biochemical, and functional parameters, were done. Serum ferritin level, cytokine storm parameters such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein 1(MCP-1), C-reactive protein, total leukocyte count, lymphocytic count, and neutrophil-to-lymphocyte ratio were measured. Anthropometric and clinical parameters showed nonsignificant differences between groups. The hematology profile showed improvement in lymphocyte count in the supplement group. However, levels of alkaline phosphatase, IL-6, TNF-α, and MCP-1 were significantly lower in the supplement group. In conclusion, antioxidant oral supplementation significantly reduced the cytokine storm and led to partial improvements in clinical parameters among patients with non-critical COVID-19. MDPI 2021-05-19 /pmc/articles/PMC8160844/ /pubmed/34069549 http://dx.doi.org/10.3390/antiox10050804 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abulmeaty, Mahmoud M. A. Aljuraiban, Ghadeer S. Shaikh, Sumaya M. ALEid, Naif E. Mazrou, Lulwa R. Al Turjoman, Abdullah A. Aldosari, Mona S. Razak, Suhail El-Sayed, Mervat M. Areabi, Tahani M. Alsalafi, Rokia M. Al-Helio, Yasser S. Almutairy, Abdulrhman B. Molla, Haneen N. The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial |
title | The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial |
title_full | The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial |
title_fullStr | The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial |
title_full_unstemmed | The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial |
title_short | The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial |
title_sort | efficacy of antioxidant oral supplements on the progression of covid-19 in non-critically ill patients: a randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160844/ https://www.ncbi.nlm.nih.gov/pubmed/34069549 http://dx.doi.org/10.3390/antiox10050804 |
work_keys_str_mv | AT abulmeatymahmoudma theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT aljuraibanghadeers theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT shaikhsumayam theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT aleidnaife theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT mazroululwaral theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT turjomanabdullaha theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT aldosarimonas theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT razaksuhail theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT elsayedmervatm theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT areabitahanim theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT alsalafirokiam theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT alhelioyassers theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT almutairyabdulrhmanb theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT mollahaneenn theefficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT abulmeatymahmoudma efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT aljuraibanghadeers efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT shaikhsumayam efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT aleidnaife efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT mazroululwaral efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT turjomanabdullaha efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT aldosarimonas efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT razaksuhail efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT elsayedmervatm efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT areabitahanim efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT alsalafirokiam efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT alhelioyassers efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT almutairyabdulrhmanb efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial AT mollahaneenn efficacyofantioxidantoralsupplementsontheprogressionofcovid19innoncriticallyillpatientsarandomizedcontrolledtrial |